Document Detail


Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.
MedLine Citation:
PMID:  24957516     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Functional mitral regurgitation (FMR) occurs when normal or nearly normal mitral leaflets are prevented from proper coaptation by underlying left ventricular (LV) dysfunction, mitral annular dilation, or both. FMR is associated with an adverse prognosis in nonischemic or ischemic LV dysfunction. Multiple studies have confirmed that even mild FMR portends a worse prognosis, and that the risk of FMR is independent of LV volumes and other clinical risk factors. FMR can be difficult to quantitate echocardiographically because it is load dependent and can vary considerably from exam to exam. There is a systematic tendency to underestimate FMR severity by echocardiography because the regurgitant orifice in FMR is typically elliptical, but the formula for calculating regurgitant orifice area assumes circular geometry. Treatment of FMR begins with guideline-directed medical therapy (GDMT) for LV dysfunction and heart failure, including cardiac resynchronization, if indicated. Revascularization should be considered for ischemic FMR, when indicated. Finally, mitral valve surgery should be considered in patients undergoing CABG in whom moderate or greater FMR is present, and also when severe symptomatic FMR persists despite optimal GDMT and revascularization. Percutaneous options for treatment of FMR are in development but are not currently approved in the US.
Authors:
Mina M Benjamin; Robert L Smith; Paul A Grayburn
Related Documents :
3756586 - Effects of brief periods of myocardial ischemia on regional myocardial function and cre...
2940856 - Performance of primary and derived m-mode echocardiographic measurements for detection ...
818116 - Digital computer analysis of m-scan echocardiograms.
22345526 - In vivo validation of longitudinal-circumferential area change ratio to estimate myofib...
2107236 - The thrombolysis in myocardial infarction (timi) trial phase ii: additional information...
7664416 - Angiotensin-converting enzyme in the human heart. effect of the deletion/insertion poly...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  16     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-06-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  517     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabolomic and Lipidomic Analysis of the Heart of Peroxisome Proliferator-Activated Receptor-? Coac...
Next Document:  Variable recombination dynamics during the emergence, transmission and 'disarming' of a multidrug-re...